Published in Brain Res on April 12, 2011
Mutations in GRIN2A cause idiopathic focal epilepsy with rolandic spikes. Nat Genet (2013) 1.59
Multiple risk pathways for schizophrenia converge in serine racemase knockout mice, a mouse model of NMDA receptor hypofunction. Proc Natl Acad Sci U S A (2013) 1.31
Glycine transporters as novel therapeutic targets in schizophrenia, alcohol dependence and pain. Nat Rev Drug Discov (2013) 1.27
The NMDA receptor co-agonists, D-serine and glycine, regulate neuronal dendritic architecture in the somatosensory cortex. Neurobiol Dis (2011) 1.04
Serine racemase deletion abolishes light-evoked NMDA receptor currents in retinal ganglion cells. J Physiol (2011) 0.85
Identity of the NMDA receptor coagonist is synapse specific and developmentally regulated in the hippocampus. Proc Natl Acad Sci U S A (2014) 0.82
An mGlu5-Positive Allosteric Modulator Rescues the Neuroplasticity Deficits in a Genetic Model of NMDA Receptor Hypofunction in Schizophrenia. Neuropsychopharmacology (2016) 0.78
Subchronic pharmacological and chronic genetic NMDA receptor hypofunction differentially regulate the Akt signaling pathway and Arc expression in juvenile and adult mice. Schizophr Res (2015) 0.75
Serine racemase is expressed in islets and contributes to the regulation of glucose homeostasis. Islets (2016) 0.75
The Regulation of GluN2A by Endogenous and Exogenous Regulators in the Central Nervous System. Cell Mol Neurobiol (2016) 0.75
NMDA receptor trafficking in synaptic plasticity and neuropsychiatric disorders. Nat Rev Neurosci (2007) 6.26
The postsynaptic architecture of excitatory synapses: a more quantitative view. Annu Rev Biochem (2007) 4.75
The incorporation of NMDA receptors with a distinct subunit composition at nascent hippocampal synapses in vitro. J Neurosci (1999) 4.37
Dendritic spine pathology: cause or consequence of neurological disorders? Brain Res Brain Res Rev (2002) 4.31
Regulatory mechanisms of AMPA receptors in synaptic plasticity. Nat Rev Neurosci (2007) 4.24
From synapse to nucleus: calcium-dependent gene transcription in the control of synapse development and function. Neuron (2008) 4.02
Neurobiology of schizophrenia. Neuron (2006) 3.69
Calmodulin-kinases: modulators of neuronal development and plasticity. Neuron (2008) 3.14
NMDA receptor surface mobility depends on NR2A-2B subunits. Proc Natl Acad Sci U S A (2006) 2.31
Glycine and N-methyl-D-aspartate receptors: physiological significance and possible therapeutic applications. Pharmacol Rev (1998) 2.28
Targeted disruption of serine racemase affects glutamatergic neurotransmission and behavior. Mol Psychiatry (2008) 1.88
Developmental switch in the expression of NMDA receptors occurs in vivo and in vitro. Neuron (1993) 1.84
Metaplasticity at single glutamatergic synapses. Neuron (2010) 1.74
Dynamic regulation of glutamatergic postsynaptic activity in rat prefrontal cortex by repeated administration of antipsychotic drugs. Mol Pharmacol (2008) 1.61
Linking Hebb's coincidence-detection to memory formation. Curr Opin Neurobiol (2000) 1.39
NMDA- and beta-amyloid1-42-induced neurotoxicity is attenuated in serine racemase knock-out mice. J Neurosci (2008) 1.27
Gene knockout of glycine transporter 1: characterization of the behavioral phenotype. Proc Natl Acad Sci U S A (2004) 1.27
Serine racemase deletion disrupts memory for order and alters cortical dendritic morphology. Genes Brain Behav (2010) 1.25
Neuroplasticity signaling pathways linked to the pathophysiology of schizophrenia. Neurosci Biobehav Rev (2010) 1.24
Serine racemase is associated with schizophrenia susceptibility in humans and in a mouse model. Hum Mol Genet (2009) 1.18
Regional distribution and developmental variation of the glycine transporters GLYT1 and GLYT2 in the rat CNS. Eur J Neurosci (1995) 1.12
NMDA receptor pharmacology: perspectives from molecular biology. Curr Drug Targets (2001) 1.08
Reduced glycine transporter type 1 expression leads to major changes in glutamatergic neurotransmission of CA1 hippocampal neurones in mice. J Physiol (2005) 1.04
Developmental expression of the glycine transporters GLYT1 and GLYT2 in mouse brain. J Neurochem (1996) 0.93
Sustained saturating level of glycine induces changes in NR2B-containing-NMDA receptor localization in the CA1 region of the hippocampus. J Neurochem (2008) 0.83
Circuit-based framework for understanding neurotransmitter and risk gene interactions in schizophrenia. Trends Neurosci (2008) 5.12
Neurobiology of schizophrenia. Neuron (2006) 3.69
Glutamatergic mechanisms in schizophrenia. Annu Rev Pharmacol Toxicol (2002) 2.88
Treating a child with Asperger's disorder and comorbid bipolar disorder. Am J Psychiatry (2002) 1.44
Multiple risk pathways for schizophrenia converge in serine racemase knockout mice, a mouse model of NMDA receptor hypofunction. Proc Natl Acad Sci U S A (2013) 1.31
Gene knockout of glycine transporter 1: characterization of the behavioral phenotype. Proc Natl Acad Sci U S A (2004) 1.27
Neuroplasticity signaling pathways linked to the pathophysiology of schizophrenia. Neurosci Biobehav Rev (2010) 1.24
Cell selective conditional null mutations of serine racemase demonstrate a predominate localization in cortical glutamatergic neurons. Cell Mol Neurobiol (2012) 1.12
Serine racemase deletion protects against cerebral ischemia and excitotoxicity. J Neurosci (2010) 1.10
Depression and bipolar support alliance consensus statement on the unmet needs in diagnosis and treatment of mood disorders in children and adolescents. J Am Acad Child Adolesc Psychiatry (2003) 1.10
Ube3a mRNA and protein expression are not decreased in Mecp2R168X mutant mice. Brain Res (2007) 1.06
The NMDA receptor co-agonists, D-serine and glycine, regulate neuronal dendritic architecture in the somatosensory cortex. Neurobiol Dis (2011) 1.04
Reduced glycine transporter type 1 expression leads to major changes in glutamatergic neurotransmission of CA1 hippocampal neurones in mice. J Physiol (2005) 1.04
Getting balance: drugs for bipolar disorder share target. Nat Med (2002) 1.00
Low cerebrospinal fluid glutamate and glycine in refractory affective disorder. Biol Psychiatry (2006) 0.99
NAAG reduces NMDA receptor current in CA1 hippocampal pyramidal neurons of acute slices and dissociated neurons. Neuropsychopharmacology (2005) 0.98
Do maternal folate and homocysteine levels play a role in neurodevelopmental processes that increase risk for schizophrenia? Harv Rev Psychiatry (2005) 0.97
Endogenous N-acetylaspartylglutamate reduced NMDA receptor-dependent current neurotransmission in the CA1 area of the hippocampus. J Neurochem (2007) 0.95
D-serine and serine racemase are localized to neurons in the adult mouse and human forebrain. Cell Mol Neurobiol (2014) 0.95
Identity of endogenous NMDAR glycine site agonist in amygdala is determined by synaptic activity level. Nat Commun (2013) 0.93
Neuronal D-serine regulates dendritic architecture in the somatosensory cortex. Neurosci Lett (2012) 0.91
The glycine transporter GlyT1 controls N-methyl-D-aspartic acid receptor coagonist occupancy in the mouse retina. Eur J Neurosci (2009) 0.89
Glutamate carboxypeptidase II gene expression in the human frontal and temporal lobe in schizophrenia. Neuropsychopharmacology (2004) 0.89
Failure of NMDA receptor hypofunction to induce a pathological reduction in PV-positive GABAergic cell markers. Neurosci Lett (2010) 0.87
The role of animal models in evaluating reasonable safety and efficacy for human trials of cell-based interventions for neurologic conditions. J Cereb Blood Flow Metab (2008) 0.86
Serine racemase deletion abolishes light-evoked NMDA receptor currents in retinal ganglion cells. J Physiol (2011) 0.85
NAAG, NMDA receptor and psychosis. Curr Med Chem (2012) 0.83
Regulation of glutamate carboxypeptidase II function in corticolimbic regions of rat brain by phencyclidine, haloperidol, and clozapine. Neuropsychopharmacology (2003) 0.82
Phenotypic characterization of mice heterozygous for a null mutation of glutamate carboxypeptidase II. Synapse (2009) 0.81
Decoding schizophrenia. Sci Am (2004) 0.81
Functional magnetic resonance imaging studies of schizophrenic patients during word production: effects of D-cycloserine. Psychiatry Res (2005) 0.80
Promoter analysis of human glutamate carboxypeptidase II. Brain Res (2007) 0.80
Discordant behavioral effects of psychotomimetic drugs in mice with altered NMDA receptor function. Psychopharmacology (Berl) (2010) 0.78
Altered acquisition and extinction of amphetamine-paired context conditioning in genetic mouse models of altered NMDA receptor function. Neuropsychopharmacology (2012) 0.78
Nitric oxide and symptom reduction in schizophrenia. JAMA Psychiatry (2013) 0.78
Time-dependent effects of haloperidol on glutamine and GABA homeostasis and astrocyte activity in the rat brain. Psychopharmacology (Berl) (2013) 0.78
Erratum: "Prevalence, heritability, and prospective risk factors for anorexia nervosa" (2006;63[3]:305-312). Arch Gen Psychiatry (2008) 0.75
Glutamate carboxypeptidase II and folate deficiencies result in reciprocal protection against cognitive and social deficits in mice: implications for neurodevelopmental disorders. Dev Neurobiol (2012) 0.75
Neuronal serine racemase regulates extracellular D-serine levels in the adult mouse hippocampus. J Neural Transm (Vienna) (2015) 0.75
The JAMA Network Journals: new names for the archives journals. Arch Dermatol (2012) 0.75
Much more than a name change. JAMA Psychiatry (2013) 0.75
The JAMA Network Journals: New Names for the Archives Journals. Arch Otolaryngol Head Neck Surg (2012) 0.75
L-type calcium channels reduce ROS generation in cerebellar granule cells following kainate exposure. Synapse (2002) 0.75
Changing to JAMA Psychiatry. Arch Gen Psychiatry (2012) 0.75
The JAMA Network Journals: New Names for the Archives Journals. Arch Neurol (2012) 0.75
Changes in JAMA and the Archives of General Psychiatry: what they mean for readers and authors. Arch Gen Psychiatry (2012) 0.75
The JAMA Network journals: new names for the archives journals. Arch Facial Plast Surg (2012) 0.75
The JAMA Network Journals: new names for the archives journals. Arch Pediatr Adolesc Med (2012) 0.75
A continuing commitment to excellence. Arch Gen Psychiatry (2002) 0.75
The JAMA Network journals: new names for the archives journals. Arch Surg (2012) 0.75
The JAMA Network Journals: New Names for the Archives Journals. Arch Ophthalmol (2012) 0.75
The JAMA network journals: new names for the archives journals. Arch Intern Med (2012) 0.75
The JAMA Network Journals: New Names for the Archives Journals. Arch Gen Psychiatry (2012) 0.75